To test whether the newly identified GR-Oct1 binding site is indeed a GC-dependent enhancer region for which the rs9493857 ancestral versus derived alleles convey differential transcriptional activity, we performed luciferase reporter assays in SK-BR-3 breast cancer cells. The gene discussed is NR3C1; the disease is breast cancer.